Home Federal Budget Tags

View the Latest: Federal Budget

Filter

List Grid

201 - 210 of 337 Results

  • Unpacking the Prescription Drug Provisions of the Build Back Better Act

    Event Date:
    Event

    As the Build Back Better Act shifts from the House to the Senate, there’s considerable interest in provisions that would lower the cost of prescription drugs. The House-passed bill would allow the federal government to negotiate prices for some high-cost drugs in Medicare, and set a hard cap on out-of-pocket drug spending for Medicare Part D enrollees.  For people with Medicare and private insurance, the legislation would limit annual increases in drug prices and cap…

  • Sustaining Medicare for the Future: What’s Next In the Debt-Reduction Debate? Briefing and Panel Discussion

    Event Date:
    Event

    As Washington continues to search for long-term solutions to reduce federal spending, with Medicare often at the forefront of these discussions, the Kaiser Family Foundation held a policy briefing Wednesday, Jan. 30, at 9:30 a.m. to explore options that could be considered to reduce Medicare spending, and their implications for beneficiaries. Kaiser Family Foundation CEO Drew Altman provided opening remarks. The briefing featured a panel discussion with three former Medicare administrators –Mark McClellan of the…

  • New Survey, Analysis Suggest a Growing Partisan Split About U.S. Government Engagement on Global Health

    News Release

    While U.S. global health programs have enjoyed bipartisan support in the past, a new survey of the public and findings from interviews with global health and foreign policy experts suggest a growing partisan divide, as the country gears up for the 2016 election. Half (53%) of Americans say the U.S. is already doing enough to improve health in developing countries, and 46 percent think the U.S. is doing more than its fair share compared to…

  • Allowing Medicare to Negotiate Drug Prices Is A Popular Idea But May Not Produce Substantial Savings

    News Release

    In response to rising drug costs, some policymakers and presidential candidates, including Republican Donald Trump and Democrats Hillary Clinton and Bernie Sanders, have proposed allowing Medicare to negotiate directly with pharmaceutical companies over the price of prescription drugs, in contrast to the current approach under Medicare Part D drug where private plans do the negotiating.  A version of this proposal was also included in the Obama Administration’s FY 2016 and FY 2017 budgets. While the…

  • The U.S. Response to Ebola: Status of the FY2015 Emergency Ebola Appropriation

    Issue Brief

    This issue brief reviews where the U.S. response to Ebola stands, asking: What specifically was funding provided for and what is its current status? How is U.S. funding being used to address the outbreak and its aftermath, and prepare for future health threats? How available and transparent is information about these activities?

  • The Future of U.S. Global Health Policy & Programs

    Event Date:
    Event

    As the U.S. enters a Presidential election year and the larger global health and development landscape changes, U.S. global health programs face a key moment of transition. The prior decade saw unprecedented attention to and funding for global health by the U.S. government. Although funding has flattened in recent years, global health has generally enjoyed significant bipartisan support in Congress and the Administration, at a level not seen in most other non-entitlement or discretionary spending…

  • Foreign Policy and Global Health Experts on the USG’s Role in Global Health

    Issue Brief

    While global health has enjoyed significant bipartisan support among US policymakers over the past 15 years, the potential for changes in the political landscape in 2016 makes this an opportune time to assess the USG’s position relative to global health needs and funding. With this in mind, the Kaiser Family Foundation’s Global Health Policy Program asked Hart Research Associates and Public Opinion Strategies to solicit the views of specialists in foreign policy and global health.

  • With or Without ACA Repeal, ACA and Medicaid Cuts are Looming

    Perspective

    In this JAMA Health Forum post, Executive Vice President Larry Levitt explores why the incoming Trump administration and Republican majorities in Congress are likely to pursue budget cuts in Medicaid and the Affordable Care Act and why such efforts are likely to boost the number of uninsured Americans.